Luis Dellamary

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee

V. Deshmukh, Haide Hu, Charlene F. Barroga et al. · Osteoarthritis and Cartilage · 2017 · 218 citations · Full text

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment

V. Deshmukh, Alyssa L. O'Green, Carine Bossard et al. · Osteoarthritis and Cartilage · 2019 · 185 citations · Full text

Hollow Porous Particles in Metered Dose Inhalers

Luis Dellamary, Thomas E. Tarara, Christopher H. Woelk et al. · Pharmaceutical Research · 2000 · 177 citations

The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models

Betty Y. Tam, Kevin Chiu, Heekyung Chung et al. · Cancer Letters · 2019 · 139 citations · Full text

Clk Inhibitor Sm08502, Wnt Pathway Genes, Pathology +19

Dose-Dependent Sustained Release of Dexamethasone in Inner Ear Cochlear Fluids Using a Novel Local Delivery Approach

Xiaobo Wang, Luis Dellamary, Rayne Fernandez et al. · Audiology and Neurotology · 2009 · 102 citations

Safe Delivery System, Health Sciences, Medicine +13